C

Cellectar Biosciences
D

CLRB

0.26980
USD
0.01
(3.81%)
مغلق
حجم التداول
13,201
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
12,432,350
أصول ذات صلة
A
ADVM
0.14600
(4.37%)
3.49000 USD
A
AFMD
-0.15020
(-13.65%)
0.94980 USD
A
AGEN
0.26000
(9.12%)
3.11000 USD
A
ARWR
0.380
(2.71%)
14.410 USD
B
BPMC
5.400
(5.44%)
104.720 USD
C
CRBP
0.26000
(3.45%)
7.79000 USD
C
CVM
-0.02000
(-7.41%)
0.25000 USD
M
MNOV
-0.02000
(-1.31%)
1.51000 USD
المزيد
الأخبار المقالات

العنوان: Cellectar Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.